Por favor, use este identificador para citar o enlazar este Item:http://hdl.handle.net/20.500.12105/17077
Título
Unanswered clinical questions in the management of cardiometabolic risk in the elderly: a statement of the Spanish society of internal medicine.
Autor(es)
Fecha de publicación
2014-12-18
Idioma
Inglés
Tipo de documento
research article
Resumen
BACKGROUND: Despite the progressive increase in life expectancy and the relationship between aging with multi-morbidities and the increased use of healthcare resources, current clinical practice guidelines (CPG) on cardiometabolic risk cannot be adequately applied to elderly subjects with multiple chronic conditions. Its management frequently becomes complicated by both, an excessive use of medications that may lead to overtreatment, drug interactions and increased toxicity, and errors in dosage and non-compliance. Concerned by this gap, the Spanish Society of Internal Medicine created a group of independent experts on cardiometabolic risk who discussed what they considered to be unanswered questions in the management of elderly patients. DISCUSSION: Current guidelines do not specifically address the problem of elderly with multiple chronic conditions. For this reason, the combined use of the limited available evidence, clinical experience and common sense, could all help us to address this unmet need. In very old people, life expectancy and functionality are the most important factors for guiding potential treatments. Their higher propensity to develop serious adverse events and their shorter lifespan could prevent them from obtaining the potential benefits of the interventions administered. SUMMARY: In this document, experts on cardiometabolic risk factors have established a number of consensual recommendations that have taken into account international guidelines and clinical experience, and have also considered the more effective use of healthcare resources. This document is intended to provide general recommendations for clinicians and to promote the effective use of procedures and medications.
Palabras clave
Anciano | Enfermedades cardiovasculares | Complicaciones de la diabetes | Hipertensión | Enfermedades metabólicas | Evaluación nutricional | Obesidad | Prevención primaria | Factores de riesgo | Prevención secundaria | España
MESH
Aged | Anticoagulants | Antihypertensive Agents | Blood Pressure Monitoring, Ambulatory | Cardiovascular Diseases | Diabetes Complications | Hydroxymethylglutaryl-CoA Reductase Inhibitors | Hypertension | Metabolic Diseases | Nutrition Assessment | Obesity | Platelet Aggregation Inhibitors | Primary Prevention | Secondary Prevention | Spain
Versión en línea
DOI
Aparece en las colecciones
Acceso a texto completo